Risk Reduction on New Drugs,

Slides:



Advertisements
Similar presentations
(The Global Programme of Research On Climate Change Vulnerability, Impacts and Adaptation) Adaptation Knowledge Day V: Climate Change Adaptation Gaps BONN,
Advertisements

CLUB DRUGS: EMERGING TRENDS AND RISKS Open Road ‘Legal Highs – Clubbing Drugs’ Conference Wednesday 23 rd January 2013 Rick Andrews National Treatment.
Do consumers of ecstasy-type pills take preventative measures to avoid bad effects from ecstasy-type pills? Dr Fairlie McIlwraith Associate Professor Rosa.
Overview of the 2010 work programme Paul Griffiths, Roland Simon, Rosemary de Sousa Scientific Committee meeting, Lisbon, November 2009.
Computer Systems Week 3: Social Issues Alma Whitfield.
Recreational Insanity With Katy MacLeod- Training and Outreach Coordinator Crew Page 1.
Type of Bussiness Fitness Center Recreation center © Copyright The Rolling Capstones, Inc.
PENNSAFE ONLINE HSSF Pennsylvania Worker & Community Right to Know Act
Addicted To Life information campaign. The project in brief Source of funding: DG Justice, Drug Prevention and Information Program Target groups:
Harm Reduction.
2 nd Training Seminar on Planning and Preparing for EHES at the National Level Key points regarding informed consent Susanna Conti Istituto Superiore di.
Polydrug use challenges – European experience International Conference: New trends in drug use: facts and solutions, Parliament of the Republic of Vilnius.
Annual report 2010: the state of the drugs problem in Europe.
Trends and developments Selected trends and some insights in prevention Vilnius, 12 November 2014 Roland Simon.
Blue Pie Productions A presentation for Blue Pie artists on how we deliver our music to the WORLD!
An overview of European trends and developments Roland Simon ECAD Meeting 2011, Varna.
Prevention and Remediation in Selected Industrial Sectors, June 2005, Ottawa NATO’s Scientific Programme Thomas Strassburger Ottawa, Canada NATO’s.
Legislative Efforts Aimed at Reducing Waste Tires Piles Along the U.S. – Mexico Border Region.
An Expansionary Approach towards the IPv6 Address Allocation Model Prof Dr Sureswaran Ramadass Director, NAv6. APRICOT 2010.
ELDD Reflection – past, present and future 29th Meeting of the Scientific Committee, 18 Nov 2008.
BIOTERRORISM AND LEGAL ISSUES: THE TEXAS EXPERIENCE NGA REGIONAL BIOTERRORISM WORKSHOP March 15, 2004 Susan K. Steeg General Counsel Texas Department of.
Suspected Economically Motivated Adulteration of FDA-Regulated Products Cosmetics and Personal Care Products John E. Bailey Executive Vice President -
Optimising Internet Bandwidth in Developing Country Higher Education Sara Gwynn INASP
Psychoactive Substances: Issues For Policy Makers Fay Watson, Secretary General, EURAD.
MSDS. Introduction This presentation will provide information on the importance, use and responsibilities involved with the MSDS program. As with many.
TEDI TEDI Trans European Drug Information Mireia Ventura – Energy control Barcelona Alexander Bücheli – City of Zurich youth counseling Streetwork.
Forecasting the labor market needs of workforce skills Budapest 26 February 2014.
Information and Network security: Lithuania Tomas Lamanauskas Deputy Director Communications Regulatory Authority (RRT) Republic of Lithuania; ENISA Liaison.
National Bureau for Drug Prevention , Warsaw.
Part of Legislative Tools and Other Means To Combat Electronic Crime.
Post-training dissemination
DRUG CHECKING TUTORIAL
MARKETING RESEARCH.
Cooperation between Government Authorities and Agencies to Achieve the Sustainable Development Goals by the Republic of Belarus Yelena Kukharevich National.
A FRUIT AND VEGETABLE PRESCRIPTION PROGRAM
NEW PSYCHOACTIVE SUBSTANCES (NPS) AND HARM REDUCTION
Magali Martinez, Agnès Cadet-Taïrou TREND UNIT, OFDT
Tackling the challenge of NPS in Israel
Outcomes, Goals, and Objectives
Recap of the First Day of
Migration Secretariat for Access to Rights and Equity Department of Social Inclusion Continuous Reporting System on International Migration in the.
Types of E-commerce Business-to-Business (B2B)
MIREIA VENTURA VILAMALA, PhD
DR. Fernando Caudevilla Energy control (ABD)
3-D Secure 2.0 What Merchants Need to Know
Pol Quintana Mireia ventura
Procurement Management
PMMA (paramethoxymethamphetamine) in “legal highs” in Spain
Closing the circle and Reviewing the plan
Legal and ethical issues
Bath Salts.
Cybersecurity in Belarus a general overview of support areas
MIGRATING TO NEW TECHNOLOGY
Drugs & The Dark Net Tim Bingham
MANCOSA Honours Marketing Research.
Implementation of the Sustainable Development Goals (SDG) in the Republic of Uzbekistan Geneva, April 12, 2017.
New Psychoactive Substances (NPS) in Deep Web Marketplaces (DWM):
Results of an international drug testing service for cryptomarket users Mireia Ventura· ABD – Energy Control 15th May 2017.
Bath Salts.
Symptoms and correlates of emergency medical treatment following the use of MDMA Dr. Larissa J. Maier Monica J. Barratt, Jason A. Ferris, & Adam R. Winstock.
Welcome to Introduction to Biology
A Spanish Drug Checking service for recreational drug users
Privacy …refers to being free from intrusion—the right to be left alone, to be free from surveillance, and to have control over the information collected.
Second European Conference on Addictive Behaviours and Dependencies
E-MARKETING.
Topic Leader Training 2012.
Communication and publications
Cronfa Update September 2017.
Skopje, 21 November 2017, General Population Survey results– launch
TEDI project (Trans European Drug Information)
Presentation transcript:

Risk Reduction on New Drugs, 1 Risk Reduction on New Drugs, a Spanish experience Risk Reduction on New Drugs, a Spanish Experience Iván Fornís Espinosa 1

2 1. The evolution of the use of new synthetic drugs in Spain. Information collected by Energy Control through its Drug Checking service and the online counseling service adressed to drug users. 2. Our proposal to provide objective information to the users of these drugs in order to conduct low-risk consumptions. Risk Reduction on New Drugs, a Spanish experience 2

What is ? 1. Risk reduction project in Spain. 2. Peer to peer actions. 3 What is ? 1. Risk reduction project in Spain. 2. Peer to peer actions. 3. Responsible drug use. 4. Resources: Development and dissemination of information Drug Checking service aimed at drug users. Risk Reduction on New Drugs, a Spanish experience 3

In recent years we have observed in our project three phenomena: 4 In recent years we have observed in our project three phenomena: 1. An increment in the number of samples of new drugs provided by the users. 2. An increment of types of new drugs, also called research chemicals or legal highs. 3. An increment in the number of requests for information about new drugs. Risk Reduction on New Drugs, a Spanish experience 4

Increment in the number of samples 5 Increment in the number of samples Risk Reduction on New Drugs, a Spanish experience 5

Increment of types of new drugs 6 Increment of types of new drugs Risk Reduction on New Drugs, a Spanish experience 6

Increment in the number of requests for information about new drugs. 7 Increment in the number of requests for information about new drugs. Risk Reduction on New Drugs, a Spanish experience 7

Peculiarities of our country on New Drugs 8 Peculiarities of our country on New Drugs 1. In Spain there hasn´t been a big expansion of the use of new drugs. 2. Little presence of the smart-shop phenomenon (or head-shop). The most important distribution channel has been on the Internet and grow-shops. 3. Adaptation of the comercial product names to spanish topics such as Mazazo, Fuego, Cocopollo, etc. Risk Reduction on New Drugs, a Spanish experience 8

Peculiarities of our country on New Drugs 9 Peculiarities of our country on New Drugs 4. we began to observe the presence of new drugs as adulterants of illicit drugs Risk Reduction on New Drugs, a Spanish experience Sold as composition Samples Ecstasy pill 2C-B 53 2C-I 4 Ecstasy (crystal) Methylone 12 Ecstasy (pill, crystal) Mephedrone 11 Cocaína 2 Methamphetamine Ketamine Methoxetamine 6 9

1010 Our approach 1. Development and dissemination of update and objective information about risk reduction on new drugs: Scientific articles Trip reports and personal communication Give information in recreational places Give information in our drug checking services Give information through web, forums and social networks Risk Reduction on New Drugs, a Spanish experience 10

1111 Our approach 2. Direct communication to general drug users about the emergence of new drugs as adulterants of other drugs to inform them (ex. PMMA in legal highs). Risk Reduction on New Drugs, a Spanish experience 11

1212 Our approach 3. Notice the proper agencies of the findings, especially the - EMCDDA - Ministry of Health - regional councils Risk Reduction on New Drugs, a Spanish experience 12

1313 Our approach 4. Updating the analysis service to expand its capacity to detect new substances in timeframes as short as possible. 5. Training project staff to have updated knowledge as possible of the phenomenon. Risk Reduction on New Drugs, a Spanish experience 13

Conclusions (1) 1414 Energy Control has only had access to samples provided voluntarily by consumers; this has allowed us to observe particularly the phenomenon of adulteration of other drugs with these new compounds. Studies of new drugs, which keep track of the products sold in stores or online head-shops, have failed to detect this phenomenon. This could add risk to consumers because these people do not take precautions to consume. Thus, having information of samples submitted by users becomes a source of invaluable information complementary to information obtained by other means (for example, direct purchases or police seizures). Risk Reduction on New Drugs, a Spanish experience 14

Conclusions (2) 1515 In this sense, having services such as drug checking service, a web-site for drug users or be present in recreational contexts allows us direct contact with consumers and work specifically with these aspects as the information on these new drugs and taking care strategies and the associated demystify certain beliefs such as greater security in front of these illegal drugs. Risk Reduction on New Drugs, a Spanish experience 15

Conclusions (3) 1616 The phenomenon of new drugs is extremely dynamic and is able to rapidly introduce new substances on the market. This causes, at times, when we are able to prepare and distribute updated information about these new drugs, these leaving the market and appear new ones. This is produced by the application of prohibitive legislation on new drugs as the only way to address the problem. Risk Reduction on New Drugs, a Spanish experience 16

Thank you Iván Fornís Espinosa (Energy Control – ABD) PMMA (paramethoxymethamphetamine) in “legal Highs” in Spain. Iván Fornís Espinosa (Energy Control – ABD) analisis@energycontrol.org info@enrgycontrol.org 17